Evolocumab Lowers Low-Density-Lipoprotein Cholesterol and Lipoprotein (A) Levels in Nephrotic Syndrome
ABSTRACT: Objectives: To present a patient with nephrotic syndrome and elevated low-density-lipoprotein (LDL) cholesterol (LDL-C) secondary to increased lipoprotein a (Lp[a]) levels and to demonstrate a decrease in Lp(a) levels secondary to evolocumab therapy.Methods: Lp(a) was measured by immunotur...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-09-01
|
| Series: | AACE Clinical Case Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060520301504 |